spacer
home > epc > Autumn 2011
PUBLICATIONS

European Pharmaceutical Contractor

epc
Autumn 2011
   
Text
PDF
bullet
Marketplace & Business

CRO Strategic Partnerships

Budding Relationships

Karyn Korieth at CenterWatch discusses how using performancebased metrics in site selection can help CROs to establish long-term relationships with those sites who are capable of delivering high-quality clinical data faster and more efficiently.

 
view
download pdf

Annual CRO Review

The Race Towards Strategic Outsourcing?

EPC’s Editor Graham Hughes reviews the CRO market in 2011, placing a strong emphasis on mergers, acquisitions, joint ventures and strategic alliances as an indication of what is to come in the industry.

 
view
download pdf
Translation: In-Country Review

Problems and Best Practices

Translations can be a sticky process,with both the actual translation and the review being time-consuming processes. Simon Andriesen of MediLingua gives us the do’s and don’ts that reviewers should bear in mind, as well as the ways in which the process can be streamlined.
 
view
download pdf
Multiregional Clinical Trials

Sourcing Comparators

Sourcing comparators for domestic clinical trials has its own challenges; when conducting global trials there are even more hurdles to overcome. Lekishia White of Multipharma, Inc describes factors to consider when choosing a comparator.
 
view
download pdf
bullet
Clinical Trials: Patient Recruitment & Retention

Clinical Patient Databases

The Population Pool

Efficient patient recruitment is one of the greatest challenges to clinical trial sponsors and can often cost many months in valuable research time. Joseph Azuri at Maccabi Healthcare Services explains how patient databases can be used to define the optimal subject population.

 
view
download pdf

Patient Recruitment: Europe

Pick and Mix

Selecting the right media platform for the recruitment of study participants in Europe depends on the individual indication and criteria of the clinical trial.Whatever the method, it is important to present enough information to provide answers to the most frequently asked questions, states Nils Drew at Clariness.

 
view
download pdf
bullet
Legal & Regulatory

Regulatory Viewpoint: India

Firm Foundations

The Indian pharmaceutical industry is the third largest in the world in terms of volume and is currently valued at about $400 million. While this is a great milestone for the region, a strong regulatory framework is essential in order to avoid losing momentum, assert Ajit Nair and Rajendra Talele of SIRO Clinpharm.

 
view
download pdf

Medical Devices: MDD Recast

Mark of Approval

Erdmann J Zippel at D-TARGET (a Premier Research Company) provides an insight into how the amendment to the Medical Device Directive has changed the approval process and has had a positive effect on patient safety, citing examples from countries in the European Union.

 
view
download pdf
Medical Devices: US and Europe

Spot the Difference

Georg A Mathis, Annick Toggenburgerand Rolf Marugg at Appletree AG compare the regulatory differences between the US and Europe when it comes to the development of medical devices.


 
view
download pdf
bullet
Clinical Development

Immunometabolism

New Therapeutic Avenues

It has become increasingly clear that the accumulation of vast amounts of fat in adipose tissue is linked to significant alterations in the immune system. Our increased understanding of the relationship between the two will help in the treatment and prevention of obesity-related disorders, explains Joseph A Cornicelli atCharles River Discovery Services.

 
view
download pdf
bullet
Drug Development & Delivery
Drug Development: Bioavailability and Solubility

Parallel Screening

Improving solubility and bioavailability is a multifaceted challenge in the drug development process, with many technologies promising varying degrees of success. Kwok Chow and Anil Kane of Patheon Inc consider the use of a parallel screening approach to provide fast, cost-effective results.
 
view
download pdf
bullet
DRUG DISCOVERY, DELIVERY & THERAPEUTICS

Medical Devices: Paediatrics

In Small Doses

Andre Muelenaer at Carilion Clinic Children’s Hospital and Alfred L Wicks at Virginia Tech University give an insight into the structure and activities of the Paediatric Trials Network and its strategic partnerships to promote the development of devices for children.

 
view
download pdf

Autoimmune Disorders: MENA Region

Unmet Needs

As autoimmune diseases become more widespread in the Middle East and North Africa, Rani Abraham at ClinTec stresses the need for more clinical trials to be performed locally, discussing those diseases with the highest incidence in the region.

 
view
download pdf

Medical Devices: Development

Ergonomically Sound

Michael P Craven and Jennifer L Martinof the Faculty of Engineering at the University of Nottingham, Multidisciplinary Assessment of Technology Centre for Healthcare (MATCH) discuss the crucial role of the end-user in the medical device product development pathway.

 
view
download pdf
bullet
CDISC & Electronic Data Capture

CDISC Update

Strength Through Collaboration

Lauren Shinaberry of PRA, and chair-elect of the CDISC Advisory Board for 2011, provides an insight into CDISC’s vision for the future and how the organisation intends to make full use of the opportunities new technology is offering.

 
view
download pdf
bullet
Data Management & IT Solutions

Early Clinical Drug Development

Flexible Study Designs

David Underwood at Quanticate provides an overview of the ways in which Phase 1 packages can be conducted more efficiently using combination, flexible protocols to speed up the time to becoming Phase 2 ready.

 
view
download pdf
bullet
Regional Focus

Global Clinical Trials: MENA Region

Shifting Sands

The Middle East and North Africa region is an exciting emerging market growth opportunity.Vladimir Misik of Quintiles presents an in-depth analysis of the region as a destination for R&D.

 
view
download pdf
Global Clinical Trials: Poland

Local Wisdom

There are many advantages to carrying out R&D in Poland. Basia Kondratowicz at Simbec Research Limited (an Altasciences Company) explores the increasing interest in the region as an emerging market in which to conduct clinical trials.


 
view
download pdf
Global Clinical Trials: Latin America

The Promise Land

Paul Braconnier, Laura Garcia and Patricia Goddard at Harrison Clinical Research Group delve into the benefits of conducting clinical trials in Latin America – looking particularly at Argentina and Mexico.

 
view
download pdf
   
spacer



Published quarterly in
February, May,
August and November

News and Press Releases

Aptar Pharma to Highlight Key Innovations Addressing Today’s Megatrends in Drug Delivery at CPHI Worldwide in Frankfurt, Germany


More info >>

White Papers

Planning the Execution of a Viral Clearance Study

Eurofins BioPharma Product Testing

Viral clearance studies are a necessary component of any regulatory submission for clinical trials or commercial product approval for all biopharmaceutical products. These studies are performed to evaluate the capability of the purification process to remove or inactivate viruses that could potentially contaminate the starting material. They are complex studies that require substantial financial and personnel resources, as well as specialized scientific expertise to perform. As such, viral clearance studies are often performed at a qualified contract testing laboratory rather than in-house. When multiple parties are involved in this process, clear communication and a comprehensive understanding of the approach and timeline is critical.
More info >>

Industry Events

BIO-Europe® 2017

6-8 November 2017, Messedamm 26 14055 Berlin Germany

The 23rd annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 3,800 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement